Lower A1C with Real-Time CGM than with Intermittently- Scanned CGM after One Year-The CORRIDA LIFE Study

Kód výsledku v IS VaVaI

<a href="https://www.isvavai.cz/riv?ss=detail&h=RIV%2F44555601%3A13430%2F22%3A43897553" target="_blank" >RIV/44555601:13430/22:43897553 - isvavai.cz</a>

Výsledek na webu

<a href="https://diabetesjournals.org/diabetes/article/71/Supplement_1/70-LB/146202/70-LB-Lower-A1C-with-Real-Time-CGM-than-with" target="_blank" >https://diabetesjournals.org/diabetes/article/71/Supplement_1/70-LB/146202/70-LB-Lower-A1C-with-Real-Time-CGM-than-with</a>

DOI - Digital Object Identifier

<a href="http://dx.doi.org/10.2337/db22-70-LB" target="_blank" >10.2337/db22-70-LB</a>

Jazyk výsledku

angličtina

Název v původním jazyce

Lower A1C with Real-Time CGM than with Intermittently- Scanned CGM after One Year-The CORRIDA LIFE Study

Popis výsledku v původním jazyce

We investigated the efficacy of real-time continuous glucose monitoring (rtCGM) and intermittently scanned continuous glucose monitoring (isCGM) on change in A1C. CORRIDA LIFE was a 12 month, real-world, non-randomized trial that assessed the impact of rtCGM (Dexcom G5 or G6) vs. isCGM (FreeStyle Libre 14-Day, Abbott) on A1C and other CGM metrics in adults with T1D. Patients on MDI therapy or CSII with no automatic functions were included. One hundred ninety-one adults with T1D (mean age 40?13 years, A1C 8.1?3.4% [65?14 mmol/mol]) participated in this study; 81 patients initiated rtCGM and 110 initiated isCGM. After 12-months, A1C was significantly lower with rtCGM vs. isCGM (7.1?3.1% [54.1?10.1 mmol/mol] vs. 7.7?3.3% [61.2?12.2 mmol/mol]) , p=0.0001. (Figure 1) The percentage of time in hypoglycemia (&lt;70 mg/dL [&lt;3.9 mmol/L]) was lower among rtCGM vs. isCGM participants (4.3?2.8% vs. 6.4?5.3%) , p=0.003) . Patients with rtCGM spent less time in clinically significant hypoglycemia (&lt;54 mg/dL [&lt;3.0 mmol/L]) (0.9?1.0% vs. 2.3?2.5%, p&lt;0.0001) and more time in target range (70-180 mg/dL [3.9-10 mmol/L]) than isCGM users (67.5?14.8% vs. 57.8?17.0%) , p=0.0002. Use of rtCGM was superior to isCGM in reducing A1C and hypoglycemia and improving other glycemic outcomes.

Název v anglickém jazyce

Lower A1C with Real-Time CGM than with Intermittently- Scanned CGM after One Year-The CORRIDA LIFE Study

Popis výsledku anglicky

We investigated the efficacy of real-time continuous glucose monitoring (rtCGM) and intermittently scanned continuous glucose monitoring (isCGM) on change in A1C. CORRIDA LIFE was a 12 month, real-world, non-randomized trial that assessed the impact of rtCGM (Dexcom G5 or G6) vs. isCGM (FreeStyle Libre 14-Day, Abbott) on A1C and other CGM metrics in adults with T1D. Patients on MDI therapy or CSII with no automatic functions were included. One hundred ninety-one adults with T1D (mean age 40?13 years, A1C 8.1?3.4% [65?14 mmol/mol]) participated in this study; 81 patients initiated rtCGM and 110 initiated isCGM. After 12-months, A1C was significantly lower with rtCGM vs. isCGM (7.1?3.1% [54.1?10.1 mmol/mol] vs. 7.7?3.3% [61.2?12.2 mmol/mol]) , p=0.0001. (Figure 1) The percentage of time in hypoglycemia (&lt;70 mg/dL [&lt;3.9 mmol/L]) was lower among rtCGM vs. isCGM participants (4.3?2.8% vs. 6.4?5.3%) , p=0.003) . Patients with rtCGM spent less time in clinically significant hypoglycemia (&lt;54 mg/dL [&lt;3.0 mmol/L]) (0.9?1.0% vs. 2.3?2.5%, p&lt;0.0001) and more time in target range (70-180 mg/dL [3.9-10 mmol/L]) than isCGM users (67.5?14.8% vs. 57.8?17.0%) , p=0.0002. Use of rtCGM was superior to isCGM in reducing A1C and hypoglycemia and improving other glycemic outcomes.

Druh

J_imp - Článek v periodiku v databázi Web of Science

CEP obor

—

OECD FORD obor

30502 - Other medical science

Projekt

—

Návaznosti

I - Institucionalni podpora na dlouhodoby koncepcni rozvoj vyzkumne organizace

Rok uplatnění

2022

Kód důvěrnosti údajů

S - Úplné a pravdivé údaje o projektu nepodléhají ochraně podle zvláštních právních předpisů

Název periodika

Diabetes

ISSN

0012-1797

e-ISSN

—

Svazek periodika

71

Číslo periodika v rámci svazku

1

Stát vydavatele periodika

US - Spojené státy americké

Počet stran výsledku

1

Strana od-do

"nestrankovano"

Kód UT WoS článku

000854899300138

EID výsledku v databázi Scopus

—